Apyx Medical Corporation APYX Noncash Interest Expense
Noncash Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Apyx Medical Corporation in its filing.
Tagged under the XBRL concept apyx:NoncashInterestExpense.
The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apyx Medical Corporation's noncash interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apyx Medical Corporation's noncash interest expense?
- Apyx Medical Corporation (APYX) reported noncash interest expense of $238K in Q1 2026.
- How has Apyx Medical Corporation's noncash interest expense changed year-over-year?
- Apyx Medical Corporation's noncash interest expense increased by 1.7% year-over-year, from $234K to $238K.
- What is the long-term trend for Apyx Medical Corporation's noncash interest expense?
- Over 2 years (2023 to 2025), Apyx Medical Corporation's noncash interest expense has grown at a 32.4% compound annual growth rate (CAGR), from $545K to $956K.
- What does noncash interest expense mean?
- This metric tracks interest-related expenses that are recognized on the income statement but do not require a cash payment during the period, such as the amortization of debt discounts or premiums. It is essential for reconciling net income to cash flow from operations. Understanding this non-cash component provides a clearer view of the company's true cash interest burden.